Sarah Will

1.2k total citations
28 papers, 626 citations indexed

About

Sarah Will is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Sarah Will has authored 28 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Sarah Will's work include Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (6 papers) and Regulation of Appetite and Obesity (5 papers). Sarah Will is often cited by papers focused on Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (6 papers) and Regulation of Appetite and Obesity (5 papers). Sarah Will collaborates with scholars based in United States, United Kingdom and Canada. Sarah Will's co-authors include Mylène Perreault, James L. Trevaskis, Stephanie Oldham, Steven J. Kirincich, James F. Tobin, Yanling Zhang, Vipin Suri, David V. Erbe, Suyue Wang and Christopher J. Rhodes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Physiological Reviews.

In The Last Decade

Sarah Will

26 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Will United States	15	239	200	163	130	109	28	626
Fenping Zheng China	16	273 1.1×	199 1.0×	147 0.9×	163 1.3×	126 1.2×	58	821
Vishal Kothari United States	11	208 0.9×	185 0.9×	186 1.1×	129 1.0×	161 1.5×	22	689
Katarina Lalić Serbia	16	284 1.2×	296 1.5×	258 1.6×	196 1.5×	168 1.5×	75	1.0k
Yunfei Pu China	9	162 0.7×	176 0.9×	178 1.1×	54 0.4×	106 1.0×	12	566
Jun Song China	14	406 1.7×	277 1.4×	142 0.9×	112 0.9×	134 1.2×	31	832
Stephan Sachs Germany	11	241 1.0×	223 1.1×	264 1.6×	234 1.8×	125 1.1×	15	721
Søs Skovsø Canada	9	288 1.2×	280 1.4×	231 1.4×	94 0.7×	186 1.7×	13	790
Itsuro Nagase Japan	13	300 1.3×	299 1.5×	394 2.4×	252 1.9×	117 1.1×	22	956
Harvey L. Katzeff United States	15	328 1.4×	319 1.6×	287 1.8×	94 0.7×	98 0.9×	18	861
Helena Corominola Spain	13	189 0.8×	100 0.5×	230 1.4×	291 2.2×	157 1.4×	21	683

Countries citing papers authored by Sarah Will

Since Specialization

Citations

This map shows the geographic impact of Sarah Will's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Will with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Will more than expected).

Fields of papers citing papers by Sarah Will

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Will. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Will. The network helps show where Sarah Will may publish in the future.

Co-authorship network of co-authors of Sarah Will

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Will. A scholar is included among the top collaborators of Sarah Will based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Will. Sarah Will is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laker, Rhianna C., Shaun Egolf, Sarah Will, et al.. (2025). GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice. Nature Communications. 16(1). 4714–4714. 1 indexed citations

MacLeod, Nicholas, Sarah Will, Fintan O’Rourke, et al.. (2025). The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer. BMC Cancer. 25(1). 543–543.

Kowalsky, Allison H., Rhianna C. Laker, Sarah Will, et al.. (2024). Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss. Molecular Metabolism. 95. 102074–102074. 14 indexed citations

McGovern, Josh, Sarah Will, Nicholas MacLeod, et al.. (2024). The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores. Cancer Medicine. 13(16). e70139–e70139. 3 indexed citations

Tyagi, Puneet, Chandresh Patel, Sergei Pechenov, et al.. (2023). Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation. Pharmaceutics. 15(10). 2436–2436. 6 indexed citations

Maurer, Martha A., Aaron M. Gilson, Jamie A. Stone, et al.. (2023). Applying RE-AIM to examine the impact of an implementation facilitation package to scale up a program for Veterans with chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 4(1). 143–143.

Tyagi, Puneet, Jari Mikkola, Sanjay Sarkhel, et al.. (2022). Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide. Pharmaceutics. 14(3). 553–553. 3 indexed citations

Pechenov, Sergei, Jefferson D. Revell, Sarah Will, et al.. (2021). Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. Scientific Reports. 11(1). 22521–22521. 55 indexed citations

Benoit, Simon, Brian Lam, Sarah Will, et al.. (2020). Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy. Molecular Metabolism. 43. 101118–101118. 12 indexed citations

10.

Boland, Brandon B., Michael B. Mumphrey, Hao Zheng, et al.. (2019). Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice. Molecular Metabolism. 25. 64–72. 28 indexed citations

11.

Hornigold, David C., Victor Howard, Sarah Will, et al.. (2018). A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice. Appetite. 127. 334–340. 31 indexed citations

12.

Boland, Michelle L., Stephanie Oldham, Brandon B. Boland, et al.. (2018). Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction. World Journal of Gastroenterology. 24(16). 1748–1765. 46 indexed citations

13.

Boland, Brandon B., Victor Howard, Sarah Will, et al.. (2018). Coadministration of GLP-1 and Y2R Receptor Agonists Synergize to Promote Muscle Glucose Uptake and Induce Diabetic Remission. Diabetes. 67(Supplement_1). 1 indexed citations

14.

Jouihan, Hani, Sarah Will, Silvia Guionaud, et al.. (2017). Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice. Molecular Metabolism. 6(11). 1360–1370. 49 indexed citations

15.

Will, Sarah, David C. Hornigold, David Baker, et al.. (2017). Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity. Current Opinion in Pharmacology. 37. 10–15. 11 indexed citations

16.

Perreault, Mylène, Feng Guo, Sarah Will, et al.. (2013). Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates. PLoS ONE. 8(5). e62616–e62616. 21 indexed citations

17.

Erbe, D.V., Lori D. Klaman, Douglas Wilson, et al.. (2009). Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling. Diabetes Obesity and Metabolism. 11(6). 579–588. 17 indexed citations

18.

Perreault, Mylène, Sarah Will, Kimberly Harding, et al.. (2009). Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice. Diabetes Obesity and Metabolism. 12(3). 234–245. 10 indexed citations

19.

Erbe, David V., Yanling Zhang, Vipin Suri, et al.. (2006). Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists. Vascular Pharmacology. 45(3). 154–162. 122 indexed citations

20.

Moriya, Masaaki, Masaru Takeshita, F. E. A. Johnson, et al.. (1988). Targeted mutations induced by a single acetylaminofluorene DNA adduct in mammalian cells and bacteria.. Proceedings of the National Academy of Sciences. 85(5). 1586–1589. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact